Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Cash flows from operating activities:
Net income	$ 49,401,181	$ 2,770,007
Adjustments to reconcile net income to net cash used in operating activities:
Accretion of investments	(344,267)	(225,762)
Other-than-temporary impairments	900,149	(0)
Realized investment gains, net	(7,356,275)	(9,463,843)
Change in fair value of equity securities	(56,839,751)	2,856,543
Amortization of cost of insurance acquired	635,815	661,257
Provision for deferred income tax expenses	10,711,564	558,916
Depreciation and depletion	1,905,768	728,887
Stock-based compensation	476,813	801,812
Charges for mortality and administration of universal life and annuity products	(5,472,812)	(5,692,118)
Interest credited to account balances	3,564,187	3,646,515
Change in accrued investment income	736,648	(629,387)
Change in reinsurance receivables	576,162	374,689
Change in policy liabilities and accruals	(3,005,006)	(3,535,674)
Change in income taxes receivable (payable)	1,337,419	(6,317,108)
Change in other assets and liabilities, net	1,204,314	3,679,893
Net cash used in operating activities	(1,568,091)	(9,785,373)
Proceeds from investments sold and matured:
Fixed maturities available for sale	11,000,000	7,558,333
Equity securities	19,742,295	7,838,385
Trading securities	102,699	0
Mortgage loans	4,512,139	17,770,810
Real estate	3,223,290	16,531,219
Notes receivable	2,197,052	4,944,143
Policy loans	1,283,752	1,453,634
Short-term investments	29,750,000	23,490,815
Total proceeds from investments sold and matured	71,811,227	79,587,339
Cost of investments acquired:
Fixed maturities available for sale	(9,040,152)	0
Equity securities	(15,468,580)	(12,454,268)
Trading securities	(102,699)	0
Mortgage loans	(5,421,945)	(2,654,293)
Real estate	(11,603,519)	(3,417,744)
Note receivable	(805,000)	(4,779,241)
Policy loans	(958,071)	(904,446)
Short-term investments	(1,910,488)	(48,473,476)
Total cost of investments acquired	(45,310,454)	(72,683,468)
Net cash provided by investing activities	26,500,773	6,903,871
Cash flows from financing activities:
Policyholder contract deposits	3,931,531	4,056,116
Policyholder contract withdrawals	(5,033,750)	(4,294,297)
Proceeds from notes payable/line of credit	0	21,500,000
Payments of principal on notes payable/line of credit	(19,000,000)	(21,500,000)
Purchase of treasury stock	(648,152)	(881,966)
Noncontrolling contributions/(distributions) of consolidated subsidiary	(103,540)	(103,540)
Net cash used in financing activities	(20,853,911)	(1,223,687)
Net increase (decrease) in cash and cash equivalents	4,078,771	(4,105,189)
Cash and cash equivalents at beginning of period	41,185,196	45,290,385
Cash and cash equivalents at end of period	$ 45,263,967	$ 41,185,196